Jerel A. Banks - Jun 13, 2023 Form 4 Insider Report for Benitec Biopharma Inc. (BNTC)

Role
Chief Executive Officer, Director
Signature
/s/ Jerel A. Banks
Stock symbol
BNTC
Transactions as of
Jun 13, 2023
Transactions value $
$0
Form type
4
Date filed
6/15/2023, 04:11 PM
Next filing
Mar 8, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNTC Options (right to buy) Award $0 +357K $0.00 357K Jun 13, 2023 Common Stock 357K $0.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options will vest in three substantially equal installments on June 13, 2024, June 13, 2025, and June 13, 2026.